PMID: 15240690Jul 9, 2004Paper

A tumor-associated glycoprotein that blocks MHC class II-dependent antigen presentation by dendritic cells

The Journal of Immunology : Official Journal of the American Association of Immunologists
Ralf GutzmerMichael S Marks

Abstract

Tumors evade immune surveillance despite the frequent expression of tumor-associated Ags (TAA). Tumor cells escape recognition by CD8(+) T cells through several mechanisms, including down-regulation of MHC class I molecules and associated Ag-processing machinery. However, although it is well accepted that optimal anti-tumor immune responses require tumor-reactive CD4(+) T cells, few studies have addressed how tumor cells evade CD4(+) T cell recognition. In this study, we show that a common TAA, GA733-2, and its murine orthologue, mouse epithelial glycoprotein (mEGP), function in blocking MHC class II-restricted Ag presentation by dendritic cells. GA733-2 is a common TAA that is expressed normally at low levels by some epithelial tissues and a subset of dendritic cells, but at high levels on colon, breast, lung, and some nonepithelial tumors. We show that ectopic expression of mEGP or GA733-2, respectively, in dendritic cells derived from murine bone marrow or human monocytes results in a dose-dependent inability to stimulate proliferation of Ag-specific or alloreactive CD4(+) T cells. Dendritic cells exposed to cell debris from tumors expressing mEGP are similarly compromised. Furthermore, mice immunized with dendritic cells ex...Continue Reading

References

Dec 1, 1987·British Journal of Cancer·G MoldenhauerG J Hämmerling
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A J LinnenbachH Koprowski
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·B FineschiJ Miller
Aug 1, 1995·The Journal of Experimental Medicine·R M Steinman, J Swanson
Oct 1, 1994·Current Opinion in Immunology·S Ostrand-Rosenberg
May 1, 1994·The Journal of Experimental Medicine·W Y HoM M Davis
Apr 1, 1994·The Journal of Cell Biology·S V LitvinovS O Warnaar
Oct 1, 1993·Immunology Today·F GarridoP L Stern
Jan 14, 1994·Cell·K A HogquistF R Carbone
Mar 1, 1996·The Journal of Experimental Medicine·T Boon, P van der Bruggen
May 16, 1997·International Journal of Cancer. Journal International Du Cancer·F Y YueG Burg
Jun 1, 1997·Immunology Today·B SeligerS Ferrone
Aug 7, 1997·International Journal of Cancer. Journal International Du Cancer·P ChauxF Martin
Aug 1, 1997·Current Opinion in Immunology·H Hengel, U H Koszinowski
Jan 1, 1997·Immunologic Research·Y Kawakami, S A Rosenberg
May 2, 1998·Science·H L Ploegh
May 23, 1998·Annual Review of Immunology·E Pamer, P Cresswell
Aug 5, 1998·Cancer Immunology, Immunotherapy : CII·H K BoxhornS L Eck
Aug 8, 1998·Trends in Cell Biology·I MellmanR M Steinman
Oct 1, 1998·Critical Reviews in Oncogenesis·S J AntoniaR A Flavell
Oct 31, 1998·Current Opinion in Immunology·D M Pardoll, S L Topalian
Dec 22, 1998·The Journal of Experimental Medicine·K HungH Levitsky
Feb 13, 1999·International Journal of Cancer. Journal International Du Cancer·S BraunK Pantel
Aug 23, 2000·Immunology Today·B SeligerS Ferrone
Sep 18, 2002·The Journal of Experimental Medicine·Adam G Schrum, Laurence A Turka

❮ Previous
Next ❯

Citations

Feb 29, 2008·Experimental & Molecular Medicine·Taek Joon YoonSe Ho Park
May 23, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Klaus PietznerJalid Sehouli
Sep 15, 2006·Journal of Immunotherapy·Christian EnsingerKurt W Schmid
Jun 28, 2005·International Journal of Cancer. Journal International Du Cancer·Ingeborg ZehbeMarkus J Maeurer
Aug 13, 2008·Expert Opinion on Biological Therapy·Florian LordickDirk Jäger
Oct 14, 2014·Journal of Gynecologic Oncology·Maria Lee
Aug 14, 2020·Immunity·Runhong ZhouZhiwei Chen
Nov 29, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B W C TseV A Heinzelmann-Schwarz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.